AzTrials
AzTrials

Focus of the Study is Smoking Cessation and PreventionNCT07895784

Effectiveness Of Project EX: A Classroom-Based Smoking Prevention And Cessation Intervention Program

A study testing Project EX in people with Focus of the Study is Smoking Cessation and Prevention and Smoking Prevention, run by University of Karachi at 1 site in Pakistan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this intervention is to learn if Project EX helps in prevention and cessation of smoking in adolescents. The main question it aims to answer is: 1. To evaluate whether students in the Project EX Intervention Group would demonstrate immediate, post and six-month effects as compared to Standard Care Control… Read more about this study

Who is it for?
Ages 14 to 18 yearsHealthy volunteers can take part
What is being tested?
Project EX
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 sitePakistan
Study dates
10 Nov 2026to 28 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

The sample selection will be done using following inclusion/ exclusion criteria:

  • Only those public and private schools will be included who will give consent for implementation of Project Ex.
  • At the time of the selection process, schools with an active, on-going health education programe with tobacco control as a key component would be excluded.
  • Only those adolescents will be included whose families will give consent to participate in study.
  • Adolescents with an age range of 14 years to 18 years would be included.
  • Adolescent who currently smoke and those who are non-smokers would both be included.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Naseem Akhtar, PhD scholar contact

00923106090031

naseempsy@gmail.com

Pakistan1 site
  • Imcbg-7/2

    Islamabad, Capital Territory

Other trials in Pakistan

About this study

The goal of this intervention is to learn if Project EX helps in prevention and cessation of smoking in adolescents. The main question it aims to answer is:

  1. To evaluate whether students in the Project EX Intervention Group would demonstrate immediate, post and six-month effects as compared to Standard Care Control Group

Researchers will compare Intervention Group with compared to Standard Care Control Group to see the effect of intervention.

Participants will receive the intervention Fill pre, post and 6 month follow-up forms.

Being tested
Project EX

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Project EXBehavioural

    Project EX consists of 8 sessions, each 40-45 minutes in length. The lessons are designed to be delivered over a 6 week period. Generally two sessions are provided per week for two weeks, followed by one session per week for the subsequent 4 weeks.

Study groups in NCT07895784
Study groupRoleWhat they receive
Intervention GroupExperimentalIntervention Group will receive the intervention which is Project EX
Receives: Behavioral: Project EX
Standard care controlNo interventionStandard care control Group will not receive the intervention which is Project EX

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in Mean motivation to quit tobacco use Score .

    Measured with self-report items on the likelihood of motivation to quit in the future. Lower scores indicate greater motivation to quit.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  2. Change from Baseline in Mean Smoking Intention Score.

    Measured with self-report items on the likelihood of smoking in the future. Lower scores indicate greater intention to smoke.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  3. Change from Baseline in Mean Tobacco norm attitude Score

    Scale assessing perceived acceptability of tobacco use among peers. Lower scores indicate more favorable attitudes toward tobacco use.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  4. Change from Baseline in Mean Self control Score

    Scale assessing self control items. Higher scores indicate greater self-control.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  5. Change from Baseline in Mean depression Score

    Measured with the Center for Epidemiologic Studies Depression Scale (CES-D). Higher scores indicate more depressive symptoms.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  6. Change from Baseline in Smoking-Related Knowledge

    Measured the health consequences of smoking. Higher scores indicate greater knowledge.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  7. Change from Baseline in Endorsement of Tobacco Use Myths

    Measured on common misconceptions about tobacco use.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  8. Change from Baseline in Tobacco Use Behavior

    Measured with self-report items on frequency and amount of tobacco use (cigarettes and other tobacco products) in the past 30 days. Higher scores indicate greater tobacco use.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  9. Change from Baseline in Quit Attempts

    Measured with self-report items on whether, and how many times, students who use tobacco tried to quit since the previous assessment.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  10. Change from Baseline in Coping

    Measured with items assessing ways of coping with stress and difficult situations without tobacco use. This scale's items are divided into good coping and bad coping

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  11. Change from Baseline in Sense of Coherence

    Measured with self reported scale assessing the extent to which students see life as comprehensible, manageable, and meaningful.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

  12. Change from Baseline in Exposure to Tobacco-Related Programming and Tobacco Advertising

    Measured with self-report items on exposure to anti-tobacco programs or messages and to pro-tobacco advertisements or promotions. Higher scores indicate greater exposure.

    Measured: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start10 Nov 2026 (estimated)
  3. Primary completion30 Mar 2027 (estimated)
  4. Study completion28 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The Quasi Experimental Pretest-Posttest Non-Equivalent Control Group (between-subject design).
Masking
None (open label)
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07895784
Sponsor's protocol ID
ICP-1(101)/7885
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: A decision regarding the sharing of IPD has not yet been made. This will be determined in consultation with the supervisor and will depend on participant consent and the ability to adequately de-identify the data.

Questions about this trial

What is this clinical trial studying?

A study testing Project EX in people with Focus of the Study is Smoking Cessation and Prevention and Smoking Prevention, run by University of Karachi at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Naseem Akhtar, PhD scholar (00923106090031, naseempsy@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in Mean motivation to quit tobacco use Score . (time frame: Baseline, 6 weeks (post-intervention), and 6 months (follow-up)). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in